Antineoplastics

Antineoplastics Reactions 1704, p39 - 2 Jun 2018 Various toxicities: case report A 9-month-old boy developed neutropenia, fungal infection, typhlitis and sepsis during induction chemotherapy with initial prednisolone followed by dexamethasone, daunorubicin, vincristine, asparaginase and cytarabine for B cell acute lymphoblastic leukaemia [routes, dosages, durations of treatments to reactions onsets and outcomes not stated]. The boy was diagnosed with B cell acute lymphoblastic leukaemia and found positive for hepatitis C virus genotype 3. Subsequently, he was started on induction chemotherapy consisting of initial eight days treatment with prednisolone followed by dexamethasone, daunorubicin, vincristine, asparaginase and cytarabine as per Children’s Oncology Group Infant Protocol. During induction therapy, he developed severe neutropenia, fungal infection, typhlitis and sepsis, and was admission to the paediatric ICU. The boy was treated with antifungals and broad-spectrum antibacterials. The paediatric gastroenterology team decided to continue chemotherapy, not actively treat hepatitis C and monitor clinical status and liver function tests. At the end of five induction therapy, a bone marrow examination showed morphological remission and minimal residual disease. Author comment: "In adults, simultaneous treatment of Hepatitis C with chemotherapy was avoided owing to greater therapy-associated toxicity". "During induction he developed severe neutropenia, sepsis, typhilitis and fungal infection". Ahmed QS, et al. Hepatitis C at presentation in a newly diagnosed infant with B Acute Lymphoblastic Leukemia. Pediatric Hematology Oncology Journal 3: 31-33, No. 1, Mar 2018. Available from: URL: http://doi.org/10.1016/j.phoj.2017.11.003 - Pakistan 803323976 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Antineoplastics

Reactions Weekly , Volume 1704 (1) – Jun 2, 2018
Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/antineoplastics-6tHKE060oo
Publisher
Springer International Publishing
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-018-46682-4
Publisher site
See Article on Publisher Site

Abstract

Reactions 1704, p39 - 2 Jun 2018 Various toxicities: case report A 9-month-old boy developed neutropenia, fungal infection, typhlitis and sepsis during induction chemotherapy with initial prednisolone followed by dexamethasone, daunorubicin, vincristine, asparaginase and cytarabine for B cell acute lymphoblastic leukaemia [routes, dosages, durations of treatments to reactions onsets and outcomes not stated]. The boy was diagnosed with B cell acute lymphoblastic leukaemia and found positive for hepatitis C virus genotype 3. Subsequently, he was started on induction chemotherapy consisting of initial eight days treatment with prednisolone followed by dexamethasone, daunorubicin, vincristine, asparaginase and cytarabine as per Children’s Oncology Group Infant Protocol. During induction therapy, he developed severe neutropenia, fungal infection, typhlitis and sepsis, and was admission to the paediatric ICU. The boy was treated with antifungals and broad-spectrum antibacterials. The paediatric gastroenterology team decided to continue chemotherapy, not actively treat hepatitis C and monitor clinical status and liver function tests. At the end of five induction therapy, a bone marrow examination showed morphological remission and minimal residual disease. Author comment: "In adults, simultaneous treatment of Hepatitis C with chemotherapy was avoided owing to greater therapy-associated toxicity". "During induction he developed severe neutropenia, sepsis, typhilitis and fungal infection". Ahmed QS, et al. Hepatitis C at presentation in a newly diagnosed infant with B Acute Lymphoblastic Leukemia. Pediatric Hematology Oncology Journal 3: 31-33, No. 1, Mar 2018. Available from: URL: http://doi.org/10.1016/j.phoj.2017.11.003 - Pakistan 803323976 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704

Journal

Reactions WeeklySpringer Journals

Published: Jun 2, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off